Proteogenomic network analysis reveals dysregulated mechanisms and potential mediators in Parkinson’s disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Proteogenomic network analysis reveals dysregulated mechanisms and potential mediators in Parkinson’s disease ; volume:15 ; number:1 ; day:31 ; month:7 ; year:2024 ; pages:1-16 ; date:12.2024
Nature Communications ; 15, Heft 1 (31.7.2024), 1-16, 12.2024
- Urheber
-
Doostparast Torshizi, Abolfazl
Truong, Dongnhu T.
Hou, Liping
Smets, Bart
Whelan, Christopher D.
Li, Shuwei
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-024-50718-x
- URN
-
urn:nbn:de:101:1-2410230841597.627233525153
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:29 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Doostparast Torshizi, Abolfazl
- Truong, Dongnhu T.
- Hou, Liping
- Smets, Bart
- Whelan, Christopher D.
- Li, Shuwei
- SpringerLink (Online service)
Ähnliche Objekte (12)
The accelerated aging model reveals critical mechanisms of late-onset Parkinson’s disease
Protein binding partners of dysregulated miRNAs in Parkinson’s disease serum
Dysregulated Wnt and NFAT signaling in a Parkinson’s disease LRRK2 G2019S knock-in model
Brain mediators of systemic oxidative stress on perceptual impairments in Parkinson’s disease
Reduced synaptic activity and dysregulated extracellular matrix pathways in midbrain neurons from Parkinson’s disease patients
Single cell analysis reveals the roles and regulatory mechanisms of type-I interferons in Parkinson’s disease
Metabolomics of blood reveals age-dependent pathways in Parkinson’s Disease
Transcriptomic analysis reveals an association of FCGBP with Parkinson’s disease
Functional genomics elucidates regulatory mechanisms of Parkinson’s disease-associated variants
Linking environmental risk factors with epigenetic mechanisms in Parkinson’s disease
Multi-omics analysis reveals the genetic aging landscape of Parkinson’s disease
Single-cell RNA sequencing reveals peripheral immunological features in Parkinson’s Disease
The accelerated aging model reveals critical mechanisms of late-onset Parkinson’s disease
Protein binding partners of dysregulated miRNAs in Parkinson’s disease serum
Dysregulated Wnt and NFAT signaling in a Parkinson’s disease LRRK2 G2019S knock-in model
Brain mediators of systemic oxidative stress on perceptual impairments in Parkinson’s disease
Reduced synaptic activity and dysregulated extracellular matrix pathways in midbrain neurons from Parkinson’s disease patients
Single cell analysis reveals the roles and regulatory mechanisms of type-I interferons in Parkinson’s disease
Metabolomics of blood reveals age-dependent pathways in Parkinson’s Disease
Transcriptomic analysis reveals an association of FCGBP with Parkinson’s disease
Functional genomics elucidates regulatory mechanisms of Parkinson’s disease-associated variants
Linking environmental risk factors with epigenetic mechanisms in Parkinson’s disease
Multi-omics analysis reveals the genetic aging landscape of Parkinson’s disease
Single-cell RNA sequencing reveals peripheral immunological features in Parkinson’s Disease
The accelerated aging model reveals critical mechanisms of late-onset Parkinson’s disease
Protein binding partners of dysregulated miRNAs in Parkinson’s disease serum
Dysregulated Wnt and NFAT signaling in a Parkinson’s disease LRRK2 G2019S knock-in model
Brain mediators of systemic oxidative stress on perceptual impairments in Parkinson’s disease
Reduced synaptic activity and dysregulated extracellular matrix pathways in midbrain neurons from Parkinson’s disease patients
Single cell analysis reveals the roles and regulatory mechanisms of type-I interferons in Parkinson’s disease
Metabolomics of blood reveals age-dependent pathways in Parkinson’s Disease
Transcriptomic analysis reveals an association of FCGBP with Parkinson’s disease
Functional genomics elucidates regulatory mechanisms of Parkinson’s disease-associated variants
Linking environmental risk factors with epigenetic mechanisms in Parkinson’s disease
Multi-omics analysis reveals the genetic aging landscape of Parkinson’s disease